The GI Genius processes images in real time with 99.7 percent sensitivity, allowing early detection of lesions. The FDA granted de novo clearance for the device in April.
The system offers a 30 percent increase in lesion detection compared to colonoscopies alone, according to West Orlando News.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
